TechNVision Ventures Ltd
Incorporated in 1980, TechNVision Ventures Ltd is in the business of providing Information Technology Products and Services.[1]
- Market Cap ₹ 3,417 Cr.
- Current Price ₹ 5,400
- High / Low ₹ 8,124 / 3,431
- Stock P/E 4,556
- Book Value ₹ 28.2
- Dividend Yield 0.00 %
- ROCE 8.80 %
- ROE 4.33 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 192 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 4.65% over last 3 years.
- Earnings include an other income of Rs.0.96 Cr.
- Working capital days have increased from 79.1 days to 222 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Information Technology Information Technology IT - Software Software Products
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.87 | 5.49 | 5.91 | 6.51 | 8.21 | 11.82 | 14.93 | 19.27 | 14.08 | 15.20 | 19.62 | 24.91 | |
| 4.71 | 5.90 | 5.70 | 6.39 | 7.89 | 11.36 | 14.34 | 18.09 | 13.30 | 12.93 | 17.22 | 22.48 | |
| Operating Profit | 0.16 | -0.41 | 0.21 | 0.12 | 0.32 | 0.46 | 0.59 | 1.18 | 0.78 | 2.27 | 2.40 | 2.43 |
| OPM % | 3.29% | -7.47% | 3.55% | 1.84% | 3.90% | 3.89% | 3.95% | 6.12% | 5.54% | 14.93% | 12.23% | 9.76% |
| 0.01 | 0.66 | 0.02 | 0.20 | 0.01 | 0.00 | 0.00 | 0.00 | 0.03 | 0.58 | 1.20 | 0.96 | |
| Interest | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.06 | 0.13 | 0.05 | 1.72 | 1.94 | 1.81 |
| Depreciation | 0.18 | 0.14 | 0.15 | 0.15 | 0.22 | 0.31 | 0.41 | 0.43 | 0.42 | 0.35 | 0.34 | 0.36 |
| Profit before tax | -0.02 | 0.09 | 0.06 | 0.16 | 0.10 | 0.14 | 0.12 | 0.62 | 0.34 | 0.78 | 1.32 | 1.22 |
| Tax % | -100.00% | 44.44% | 66.67% | 50.00% | -20.00% | 0.00% | 25.00% | 90.32% | 41.18% | 28.21% | 26.52% | 38.52% |
| 0.01 | 0.05 | 0.02 | 0.08 | 0.12 | 0.14 | 0.09 | 0.06 | 0.21 | 0.57 | 0.98 | 0.75 | |
| EPS in Rs | 0.02 | 0.08 | 0.03 | 0.13 | 0.19 | 0.22 | 0.14 | 0.10 | 0.33 | 0.91 | 1.56 | 1.20 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 11% |
| 3 Years: | 21% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 53% |
| 3 Years: | 53% |
| TTM: | -23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 50% |
| 5 Years: | 92% |
| 3 Years: | 196% |
| 1 Year: | 34% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 3% |
| 3 Years: | 5% |
| Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 |
| Reserves | 8.33 | 8.38 | 8.40 | 8.49 | 8.60 | 8.74 | 8.84 | 8.89 | 9.10 | 9.68 | 10.66 | 11.41 |
| 3.39 | 2.03 | 0.68 | 0.60 | 0.00 | 0.00 | 0.00 | 1.83 | 1.98 | 15.35 | 14.45 | 19.80 | |
| 2.62 | 1.85 | 0.99 | 0.98 | 0.96 | 1.37 | 2.43 | 2.15 | 1.58 | 8.23 | 8.73 | 7.13 | |
| Total Liabilities | 20.62 | 18.54 | 16.35 | 16.35 | 15.84 | 16.39 | 17.55 | 19.15 | 18.94 | 39.54 | 40.12 | 44.62 |
| 0.28 | 0.45 | 0.47 | 0.78 | 0.88 | 1.18 | 1.20 | 1.07 | 1.10 | 0.97 | 1.59 | 1.50 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 9.53 | 9.53 | 9.53 | 9.53 | 9.53 | 9.53 | 9.54 | 9.54 | 9.54 | 9.54 | 9.54 | 10.40 |
| 10.81 | 8.56 | 6.35 | 6.04 | 5.43 | 5.68 | 6.81 | 8.54 | 8.30 | 29.03 | 28.99 | 32.72 | |
| Total Assets | 20.62 | 18.54 | 16.35 | 16.35 | 15.84 | 16.39 | 17.55 | 19.15 | 18.94 | 39.54 | 40.12 | 44.62 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.75 | 0.00 | 1.68 | 0.66 | 1.19 | -0.20 | 0.48 | 0.36 | 2.45 | -13.37 | 0.19 | -4.56 | |
| -1.32 | 0.00 | -0.17 | -0.46 | -0.31 | -0.61 | -0.44 | -0.30 | -0.44 | -0.23 | -0.95 | -1.13 | |
| -0.30 | 0.00 | -2.17 | -0.09 | -0.61 | -0.01 | -0.06 | -0.13 | -0.04 | 11.92 | 0.76 | 5.49 | |
| Net Cash Flow | 0.13 | 0.00 | -0.65 | 0.11 | 0.27 | -0.82 | -0.02 | -0.07 | 1.97 | -1.68 | 0.00 | -0.20 |
| Free Cash Flow | 1.66 | 0.00 | 1.51 | 0.20 | 0.88 | -0.81 | 0.05 | 0.06 | 2.01 | -13.60 | -0.76 | -4.84 |
| CFO/OP | 1,094% | 0% | 800% | 550% | 372% | -43% | 81% | 31% | 314% | -589% | 8% | -188% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 670.79 | 424.17 | 305.09 | 259.03 | 152.05 | 111.17 | 24.69 | 25.38 | 82.18 | 48.27 | 3.35 | 0.00 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 670.79 | 424.17 | 305.09 | 259.03 | 152.05 | 111.17 | 24.69 | 25.38 | 82.18 | 48.27 | 3.35 | 0.00 |
| Working Capital Days | 652.05 | 406.22 | 282.86 | 233.80 | 146.71 | 121.67 | 98.28 | 80.31 | 62.99 | 45.62 | -29.95 | 221.70 |
| ROCE % | -0.06% | 0.63% | 0.50% | 1.11% | 0.73% | 1.00% | 1.19% | 4.67% | 2.27% | 10.27% | 10.40% | 8.80% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Count |
|
||||||||||
| Number of Product Categories (Solix CDP) Count |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Solix Technologies Names Dr. Ujwala Director Of Technical Product Management To Lead Life Sciences And AI Transformation
4h - Solix Technologies appointed Dr. Ujwala Director of Technical Product Management to drive Life Sciences and AI transformation.
- Legible Audited Financial Results 31.03.2026 27 May
- Audited Financial Results For The Quarter And Year Ended 31.03.2026 27 May
-
Board Meeting Outcome for Outcome Of Board Meeting_27052026
27 May - Board approved audited standalone and consolidated FY2026 results and appointed internal auditor.
-
Board Meeting Intimation for Approve And Take On Record The Audited Financial Results For The Quarter And Year Ended 31.03.2026.
22 May - Board meeting on 27 May 2026 to approve audited FY2026 and Q4 results; trading window closed from 1 April 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:
TNVVL offers a suite of
enterprise software and consulting
solutions focused on information
management, cash flow optimization,
and digital talent management. It also
streamlines critical business functions
for global clientele and provides support
for automation, compliance, and business process transformation.